Multicentric Phase III Study in first line treatment of advanced metastatic breast cancer (ABC). Epirubicin / Paclitaxel (ET) vs Epirubicin / Cyclophosphamide (EC). A study of the Ago Breast Cancer Group (abstr). - Lück,H.J.; Thomssen,C.; Untch,M. (Proc Am Soc Clin Oncol, 2000)